login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PROTHENA CORP PLC (PRTA) Stock News
USA
- NASDAQ:PRTA -
IE00B91XRN20
-
Common Stock
8.3
USD
-0.13 (-1.54%)
Last: 9/12/2025, 2:01:42 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRTA Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Zacks Investment Research
- Mentions:
AMRN
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
10 days ago - By: Benzinga
- Mentions:
IVA
PRIM
AMG
CHE
...
Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
14 days ago - By: Benzinga
- Mentions:
BIIB
LLY
FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy
15 days ago - By: Prothena Corporation plc
Prothena to Participate in the Cantor Fitzgerald Global Healthcare Conference
16 days ago - By: Prothena Corporation plc
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
a month ago - By: Stocktwits
- Mentions:
NVO
NVS
Novo Nordisk Commits To Advancing Prothena Corp-Developed Drug Into Late Stage Trial: Retail Turns Hopeful
a month ago - By: Prothena Corporation plc
Prothena Announces that Novo Nordisk Will Advance Coramitug (Formerly PRX004) into Phase 3 Development for ATTR Amyloidosis with Cardiomyopathy
a month ago - By: The Motley Fool
Prothena Q2 Revenue Drops 97%
a month ago - By: Zacks Investment Research
- Mentions:
GYRE
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
a month ago - By: Prothena Corporation plc
Prothena Reports Second Quarter 2025 Financial Results and Business Highlights
2 months ago - By: Zacks Investment Research
- Mentions:
RYTM
Earnings Preview: Rhythm Pharmaceuticals, Inc. (RYTM) Q2 Earnings Expected to Decline
2 months ago - By: Prothena Corporation plc
Prothena to Report Second Quarter 2025 Financial Results on August 4
2 months ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?
3 months ago - By: Stocktwits
Prothena Shares Get A Boost After Company Slashes Workforce, Lowers 2025 Cash Burn Forecast
3 months ago - By: Prothena Corporation plc
Prothena Announces Corporate Restructuring
3 months ago - By: Yahoo Finance
- Mentions:
MS
VZ
WDC
Why Western Digital Is a ‘Key Name’ in IT Hardware for Morgan Stanley
3 months ago - By: Yahoo Finance
- Mentions:
VZ
ROG
Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA)
3 months ago - By: Yahoo Finance
- Mentions:
GOOG
META
NVS
MTZ
...
2 Top Artificial Intelligence Stocks to Buy Right Now
3 months ago - By: Prothena Corporation plc
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease
4 months ago - By: Yahoo Finance
- Mentions:
GS
BAH
EXTR
AAP
...
Goldman Sachs Downgrades Booz Allen Hamilton to Sell, Cuts PT
4 months ago - By: Yahoo Finance
- Mentions:
OWL
CRWV
BAH
EXTR
...
Blue Owl Invests Additional $750M in AI Data Center Joint Venture
4 months ago - By: Yahoo Finance
- Mentions:
CHKP
LULU
DHI
CMG
Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform
4 months ago - By: Yahoo Finance
- Mentions:
LLY
NOW
BIIB
DJT
...
Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition
4 months ago - By: Yahoo Finance
- Mentions:
JACK
TFC
AAT
AMZN
...
Truist Downgrades Jack In the Box Amid Slowing Same Store Sales
4 months ago - By: Yahoo Finance
- Mentions:
DHI
CMG
TSLA
NVDA
Jefferies Downgrades Prothena Corporation (PRTA) After Negative Trial Results
4 months ago - By: Zacks Investment Research
- Mentions:
BMY
NVO
Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down
4 months ago - By: Yahoo Finance
- Mentions:
AMD
HSBC
JPM
MSM
...
AMD, Block upgraded: Wall Street's top analyst calls
Please enable JavaScript to continue using this application.